Site 107
Pathum Wan, Bangkok, Thailand
4 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 2
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves Disease
Yarrow Bioscience, Inc.232 enrolled30 locationsNCT07682896
Recruiting
Phase 3
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Merus B.V.600 enrolled218 locationsNCT06496178
Recruiting
Phase 3
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Head and Neck Squamous Cell Carcinoma
Merus B.V.700 enrolled205 locationsNCT06525220
Recruiting
Phase 2
A Study of SPY072 in Rheumatic Disease
Rheumatoid ArthritisPsoriatic ArthritisRheumatic Diseases+5 more
Spyre Therapeutics, Inc.285 enrolled64 locationsNCT07148414
Recruiting
Phase 2
Study of JK07 in Patients With Chronic Heart Failure
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction
Salubris Biotherapeutics Inc282 enrolled62 locationsNCT06369298
Recruiting
Not Applicable
A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children
Myopia
Bausch & Lomb Incorporated418 enrolled11 locationsNCT06305663
Recruiting
Phase 1Phase 2
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
Advanced Solid Tumor
DualityBio Inc.1,123 enrolled30 locationsNCT05438329